LifeStance Health Group (LFST) to Release Earnings on Wednesday

LifeStance Health Group (NASDAQ:LFST) is expected to issue its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings of $0.0539 per share and revenue of $378.5140 million for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 25, 2026 at 8:30 AM ET.

LifeStance Health Group Price Performance

Shares of NASDAQ:LFST opened at $7.04 on Wednesday. LifeStance Health Group has a one year low of $3.74 and a one year high of $8.30. The stock has a market capitalization of $2.74 billion, a price-to-earnings ratio of -234.67 and a beta of 1.12. The company has a 50-day simple moving average of $7.08 and a 200-day simple moving average of $6.06. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58.

Analysts Set New Price Targets

Several analysts have commented on the company. Barclays initiated coverage on LifeStance Health Group in a research note on Tuesday, December 9th. They set an “overweight” rating and a $8.00 price objective for the company. BMO Capital Markets started coverage on LifeStance Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $8.00 price target for the company. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 5th. Wall Street Zen raised shares of LifeStance Health Group from a “hold” rating to a “buy” rating in a research note on Sunday, February 8th. Finally, BTIG Research upped their price objective on shares of LifeStance Health Group from $10.00 to $11.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Two investment analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.00.

Insiders Place Their Bets

In related news, insider Lisa K. Miller sold 57,240 shares of the business’s stock in a transaction dated Friday, November 21st. The shares were sold at an average price of $6.43, for a total transaction of $368,053.20. Following the sale, the insider owned 261,292 shares of the company’s stock, valued at approximately $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Ann Varanakis sold 50,000 shares of the company’s stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $6.90, for a total transaction of $345,000.00. Following the transaction, the insider owned 315,610 shares in the company, valued at $2,177,709. The trade was a 13.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 327,326 shares of company stock worth $2,259,317. 6.60% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On LifeStance Health Group

Institutional investors and hedge funds have recently modified their holdings of the company. Bayesian Capital Management LP purchased a new stake in LifeStance Health Group during the second quarter worth $52,000. Cibc World Markets Corp acquired a new position in shares of LifeStance Health Group during the 4th quarter worth $77,000. Qtron Investments LLC acquired a new position in shares of LifeStance Health Group during the 4th quarter worth $83,000. Northwestern Mutual Wealth Management Co. boosted its position in shares of LifeStance Health Group by 569.1% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 12,024 shares of the company’s stock worth $85,000 after buying an additional 10,227 shares in the last quarter. Finally, Orion Porfolio Solutions LLC acquired a new stake in LifeStance Health Group in the 4th quarter valued at about $88,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.